Investigational drug · Phase 2
VUM02
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Steroid-refractory Acute Graft-versus-host Disease.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 6, 2024 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "VUM02"
First trial start
2025
Jan 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "VUM02", any sponsor or status.
Conditions studied
As listed on its trial records.
- Steroid-refractory Acute Graft-versus-host Disease
Largest trials
Live from ClinicalTrials.gov: studies naming "VUM02" as an intervention, largest first.
- A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) TreatmentPivotal-lookingNot yet recruiting
Wuhan Optics Valley Vcanbiopharma Co., Ltd.Industry
NCT06677255 · 149 participants (planned) · Start Jan 2025 · Primary completion Dec 2026
Drug: VUM02 Injection (UC-MSCs)+BAT · For: Steroid-refractory Acute Graft-versus-host Disease
Sites: Wuhan, China
Wuhan Optics Valley Vcanbiopharma Co., Ltd.Industry
NCT06230822 · 9 participants · Start Mar 5, 2024 · Primary completion Mar 13, 2025
Drug: VUM02 Injection · For: Idiopathic Pulmonary Fibrosis
Sites: Beijing, China; Chengdu, China; Guangzhou, China · 4 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Steroid-refractory Acute Graft-versus-host Disease
- MC0518Phase 32 trials
medac GmbH · Steroid-refractory Acute Graft-versus-host Disease
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.